Rodger P McEver Selected Research

P-selectin ligand protein

8/2012	Tyrosine replacement of PSGL-1 reduces association kinetics with P- and L-selectin on the cell membrane.
10/2011	Carcinoma mucins trigger reciprocal activation of platelets and neutrophils in a murine model of Trousseau syndrome.
12/2008	A role for leukocyte-endothelial adhesion mechanisms in epilepsy.
6/2003	CD8+ T cells from patients with acute multiple sclerosis display selective increase of adhesiveness in brain venules: a critical role for P-selectin glycoprotein ligand-1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rodger P McEver Research Topics

Disease

21	Inflammation (Inflammations) 01/2020 - 03/2002
3	Venous Thrombosis (Deep-Vein Thrombosis) 01/2019 - 03/2002
3	Wounds and Injuries (Trauma) 01/2019 - 12/2010
3	Thrombosis (Thrombus) 01/2019 - 10/2011
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2017 - 08/2015
2	Neoplasm Metastasis (Metastasis) 04/2016 - 12/2015
2	Neoplasms (Cancer) 04/2016 - 12/2015
2	Contact Dermatitis (Eczema, Contact) 01/2016 - 12/2010
2	Atherosclerosis 01/2016 - 08/2015
2	Reperfusion Injury 08/2015 - 07/2015
2	Infections 07/2015 - 01/2013
2	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2006 - 02/2004
1	Aneurysm (Aneurysms) 01/2021
1	COVID-19 01/2021
1	Atherosclerotic Plaque (Atheroma) 01/2016
1	Sepsis (Septicemia) 12/2014
1	Carcinoma (Carcinomatosis) 10/2011
1	Mucinous Adenocarcinoma (Mucinous Carcinoma) 10/2011
1	Epilepsy (Aura) 12/2008
1	Seizures (Absence Seizure) 12/2008
1	Type 2 von Willebrand Disease 09/2008
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 02/2008
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 11/2004
1	Hemorrhage 02/2004
1	Hemophilia A (Haemophilia) 08/2003
1	Multiple Sclerosis 06/2003

Drug/Important Bio-Agent (IBA)

14	SelectinsIBA 01/2020 - 09/2002
7	P-SelectinIBA 01/2019 - 03/2002
6	LigandsIBA 10/2011 - 01/2004
4	IntegrinsIBA 01/2020 - 11/2013
4	P-selectin ligand proteinIBA 08/2012 - 06/2003
2	AntibodiesIBA 01/2019 - 06/2003
2	Thromboplastin (Tissue Factor)IBA 01/2017 - 08/2003
2	epsinIBA 04/2016 - 12/2015
2	silk elastin-like protein (SELP)IBA 01/2016 - 01/2016
2	CytokinesIBA 01/2016 - 02/2008
2	MucinsIBA 10/2011 - 12/2008
2	Polysaccharides (Glycans)IBA 10/2008 - 02/2004
2	Tn antigenIBA 01/2006 - 02/2004
1	Viral ProteinsIBA 01/2021
1	Angiopoietin-1IBA 01/2021
1	Histamine (Histamine Dihydrochloride)FDA Link 01/2019
1	Oncostatin MIBA 01/2019
1	Messenger RNA (mRNA)IBA 01/2016
1	Apolipoproteins E (ApoE)IBA 01/2016
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2016
1	UbiquitinIBA 12/2015
1	Peptides (Polypeptides)IBA 12/2015
1	Phosphotransferases (Kinase)IBA 12/2015
1	LectinsIBA 08/2015
1	TalinIBA 07/2015
1	ChemokinesIBA 07/2015
1	Neuraminidase (Sialidase)IBA 12/2014
1	GlycoconjugatesIBA 01/2013
1	Warfarin (Coumadin)FDA LinkGeneric 10/2011
1	Heparin (Liquaemin)FDA LinkGeneric 10/2011
1	L-SelectinIBA 10/2011
1	Thrombin FDA Link 10/2011
1	single bondIBA 09/2011
1	Biological ProductsIBA 03/2011
1	RNA (Ribonucleic Acid)IBA 12/2010
1	1-nitrohydroxyphenyl-N-benzoylalanine (GAL 1)IBA 05/2010
1	Cell Adhesion MoleculesIBA 12/2008
1	Integrin alpha ChainsIBA 12/2008
1	Blocking AntibodiesIBA 12/2008
1	Platelet Membrane GlycoproteinsIBA 09/2008
1	E-SelectinIBA 02/2008
1	CD11b AntigenIBA 02/2008
1	Immunoglobulins (Immunoglobulin)IBA 08/2003
1	FibrinIBA 08/2003
1	Pharmaceutical PreparationsIBA 06/2003

Therapy/Procedure

1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2016
1	Therapeutics 12/2015
1	Ligation 12/2014
1	Punctures 12/2014